Phase III, Randomized, Double-blind, Placebo controlled trial of Efficacy, Safety and Tolerability of Antiviral drug Umifenovir vs Standard care of therapy in non-severe COVID-19 patients.
作者:
主题词
成年人(Adult);抗病毒药(Antiviral Agents);双盲法(Double-Blind Method);人类(Humans);吲哚类(Indoles);硫化物(Sulfides);治疗结果(Treatment Outcome)
DOI
10.1016/j.ijid.2021.11.025
PMID
34801738
发布时间
2022-05-31
- 浏览0
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文